Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org
-- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Friday, April 8, 2016
Thursday, April 7, 2016
A patient developed a cerebral Nocardia infection while taking the immunosuppressive agent alemtuzumab (Lemtrada) for relapsing-remitting multiple sclerosis, adding to a list of opportunistic infections seen with the drug, researchers said.
The woman, in her late 40s, developed the infection 5 months after an initial course of alemtuzumab. Her history of anorexia may have contributed to the problem, Thomas Korn, MD, of Technische Universitat Munchen in Germany, and colleagues reported online in JAMA Neurology.